3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Mouth Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Uterine Cervical Neoplasms
1
Sentinel Lymph Node Biopsy (SLNB)
1
Sarcoidosis, Pulmonary
1
Sarcoidosis
1
Rhabdomyosarcoma
1
Recurrence
1
Recurent Vulvar Carcinoma
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Melanoma
1
Lymphoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
HIV Infections
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Eyelid Sebaceous Gland Carcinoma
1
Cervical Adenocarcinoma
1
Carcinoma, Ductal
1
Anus Neoplasms
1
Interventions
pembrolizumab
18
Nivolumab
13
avelumab
10
Ipilimumab
7
Specimen Handling
6
cemiplimab
5
atezolizumab
5
Magnetic Resonance Spectroscopy
5
Biopsy
5
Radiotherapy
3
Cyclophosphamide
3
prednylidene
2
poly ICLC
2
lutetium Lu 177 dotatate
2
fludarabine phosphate
2
fludarabine
2
durvalumab
2
deltacortene
2
aldesleukin
2
Radiosurgery
2
Prednisone
2
Interleukin-2
2
Immunoglobulin G
2
Docetaxel
2
CTLA-4 Antigen
2
Bevacizumab
2
tocilizumab
1
talimogene laherparepvec
1
sargramostim
1
relatlimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Merkel Cell
×
Sentinel Lymph Node Biopsy
×
1 year
×
Clear all
No trials found.